Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at CZK 2.1T, ahead of Eli Lilly (CZK 1.45T) and Merck & Co (CZK 1.45T). Figures as of 20 Nov 2026, 23:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonCZK 2.1T
- Median
- CZK 30.7B
- Combined market value
- CZK 83.21T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 2.1T | CZK 14.5T | CZK 6,024.45 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | CZK 1.45T | CZK 26.73T | CZK 30,005.53 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | CZK 1.45T | CZK 7.34T | CZK 2,978.48 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | CZK 1.39T | CZK 3.48T | CZK 610.31 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | CZK 1.36T | CZK 11.27T | CZK 6,374.82 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | CZK 1.07T | CZK 2.68T | CZK 1,309.71 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | CZK 987.4B | CZK 3.97T | CZK 2,294.22 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | CZK 319.5B | CZK 2.12T | CZK 20,507.45 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | CZK 318.5B | CZK 501.3B | CZK 437.24 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | CZK 267.3B | CZK 2.91T | CZK 11,471.56 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | CZK 210.9B | CZK 716B | CZK 1,762.10 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | CZK 105B | CZK 286.6B | CZK 573.33 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | CZK 82.7B | CZK 429.1B | CZK 3,203.45 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | CZK 71.8B | CZK 260.6B | CZK 1,345.57 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | CZK 70.9B | CZK 526.2B | CZK 12,356.06 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | CZK 67.2B | CZK 163.9B | CZK 470.43 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | CZK 53B | CZK 876.7B | CZK 1,524.66 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | CZK 38.5B | CZK 105B | CZK 1,256.70 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | CZK 22.9B | CZK 65.9B | CZK 339.68 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 21.3B | CZK 196.2B | CZK 8,444.07 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | CZK 21B | CZK 98.6B | CZK 592.04 | 2.35% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 18.5B | CZK 130.3B | CZK 921.48 | 5.22% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | CZK 17B | CZK 155.1B | CZK 1,417.07 | 2.09% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | CZK 14.2B | CZK 151.6B | CZK 2,881.36 | 4.66% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | CZK 13.7B | CZK 213.2B | CZK 1,410.84 | 2.37% down | 103% up | ||
| 26 | InsmedINSM · Health Care | CZK 13.5B | CZK 690.6B | CZK 3,147.98 | 2.17% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | CZK 11.6B | CZK 139.8B | CZK 2,141.20 | 0.65% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | CZK 11.2B | CZK 329.9B | CZK 1,693.49 | 2.75% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | CZK 10.9B | CZK 100.5B | CZK 1,046.88 | 2.69% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | CZK 6B | CZK 127.8B | CZK 6,389.30 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 4.2B | CZK 173.5B | CZK 2,502.71 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | CZK 2B | CZK 157.6B | CZK 1,131.07 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | CZK 1B | CZK 176.5B | CZK 2,704.06 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | CZK 45.3M | CZK 106.1B | CZK 1,883.27 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | CZK 0 | CZK 197.7B | CZK 2,081.95 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | CZK 0 | CZK 187B | CZK 6,691.78 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2740 CZK). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (CZK 2.1T), Eli Lilly (CZK 1.45T) and Merck & Co (CZK 1.45T) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 23:03 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of CZK 83.21T as of 20 Nov 2026, 23:03 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.